Home » Stocks » FMS

Fresenius Medical Care AG & Co. (FMS)

Stock Price: $40.77 USD 0.11 (0.27%)
Updated Jul 23, 2021 4:00 PM EDT - Market closed
Market Cap 23.88B
Revenue (ttm) 17.86B
Net Income (ttm) 1.16B
Shares Out 585.78M
EPS (ttm) 2.28
PE Ratio 17.91
Forward PE 17.54
Dividend $1.52
Dividend Yield 3.73%
Trading Day July 23
Last Price $40.77
Previous Close $40.66
Change ($) 0.11
Change (%) 0.27%
Day's Open 40.71
Day's Range 40.65 - 40.96
Day's Volume 293,725
52-Week Range 33.16 - 44.85

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Plenty of investors focus in on dividends, and dividend aristocrats, but if those investors only look in the U.S. they could be missing out. The post 15 European Dividend Aristocrats to Diversify Your P...

Other stocks mentioned: ASHTY, BTI, DEO, ESLOY, LRLCY, NSRGY, NVS ...
2 days ago - InvestorPlace

Fresenius Medical (FMS) company receives expedited approval from NMPA permitting the Xenios AG's console and patient kits for ECMO therapy in China.

1 week ago - Zacks Investment Research

Fresenius Medical (FMS) inaugurates new training center in Korea to help in the improvement of patient care by offering comprehensive education programs for healthcare professionals.

3 weeks ago - Zacks Investment Research

HONG KONG--(BUSINESS WIRE)-- #chronickidneydisease--Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, recently announced the grand openin...

3 weeks ago - Business Wire

Fresenius Medical's (FMS) first-quarter earnings benefit from organic growth in Health Care Products segment, and performance in Asia Pacific.

2 months ago - Zacks Investment Research

HONG KONG--(BUSINESS WIRE)-- #IND2021--Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, today announced an international campaign that r...

2 months ago - Business Wire

DALLAS, March 9, 2021 /PRNewswire/ -- Kidney dialysis patients across East Texas may have failed to receive critical medical treatment due to communication failures at facilities owned by Fresenius Medi...

4 months ago - PRNewsWire

HONG KONG--(BUSINESS WIRE)-- #ChooseToChallenge--Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, has today launched its Asia Pacific Wo...

4 months ago - Business Wire

Fresenius Medical's (FMS) fourth-quarter earnings benefit from strength in Health Care Products segment, and performance across EMEA and Asia Pacific.

5 months ago - Zacks Investment Research

Shares of Fresenius Medical Care (NYSE:FMS) rose 0.0% after the company reported Q4 results. Quarterly Results Earnings per share fell 50.00% year over year to $0.76, which missed the estimate of $0.77.

5 months ago - Benzinga

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest v...

6 months ago - Zacks Investment Research

Here are some dirt-cheap MedTech value stocks which are expected to provide long-term gains in 2021.

Other stocks mentioned: DGX, HSIC, IVC
6 months ago - Zacks Investment Research

WALTHAM, Mass., Jan. 11, 2021 /PRNewswire/ -- Fresenius Medical Care, the world's leading provider of products and services for people with chronic kidney failure, announced today that the company's Fre...

6 months ago - PRNewsWire

Fresenius Medical Care might not be a ten-bagger in the next few years. Conversely, the stock currently offers a very good risk/reward ratio.

6 months ago - Seeking Alpha

Fresenius (FMS) is well positioned to outperform the market, as it exhibits above-average growth in financials.

6 months ago - Zacks Investment Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest v...

6 months ago - Zacks Investment Research

Fresenius Medical (FMS) continues to gain traction from its broad range of dialysis products and services. However, intense competition remains a woe.

7 months ago - Zacks Investment Research

Is Fresenius Medical Care (FMS) a great pick from the value investor's perspective right now? Read on to know more.

7 months ago - Zacks Investment Research

David Herro (Trades, Portfolio), a portfolio manager of the Oakmark International Fund, disclosed this week that the fund's top four trades during the third quarter included new positions in Fresenius M...

Other stocks mentioned: BUD, DMLRY
7 months ago - GuruFocus

The German Dividend Aristocrats (GDA) have been updated - this is the 2020 version. There are 53 (-1) identified Dividend Aristocrats in Germany as of November 2020.

Other stocks mentioned: FUPBY
7 months ago - Seeking Alpha

Fresenius Medical's (FMS) third-quarter earnings benefit from stable segmental performance.

8 months ago - Zacks Investment Research

Despite the correction, stocks - especially US stocks - are still trading at very high multiples and it is difficult to find bargains. Bayer and Fresenius are two German large-cap stocks that are tradin...

Other stocks mentioned: BAYRY, CVS, MMM
8 months ago - Seeking Alpha

Fresenius Medical Care AG & Co. KGaA (FMS) CEO Robert Powell on Q3 2020 Results - Earnings Call Transcript

8 months ago - Seeking Alpha

Fresenius delivered very solid results despite the pandemic. Importantly, all guidance was confirmed.

8 months ago - Seeking Alpha

Fresenius Medical Care's Unexciting Capital Markets Day

9 months ago - Seeking Alpha

Fresenius Medical (FMS) continues to gain traction from its broad range of dialysis products and services. However, intense competition remains a woe.

9 months ago - Zacks Investment Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest v...

9 months ago - Zacks Investment Research

FMS vs. SMLR: Which Stock Is the Better Value Option?

Other stocks mentioned: SMLR
9 months ago - Zacks Investment Research

Let's grab these three stocks that have continued to show tremendous promise despite market volatility resulting from the coronavirus pandemic.

Other stocks mentioned: HOLX, TMO
10 months ago - Zacks Investment Research

Fresenius Medical Care Asia Pacific responds to call for education in preparation of ultrapure dialysis fluid in developing economies

10 months ago - Business Wire

While searching for a suitable value investment option, investors are unlikely to consider PEG ratio among a number of other popular value metrics.

Other stocks mentioned: HBI, RBC, WHR
10 months ago - Zacks Investment Research

Here are some dirt-cheap MedTech value stocks which have been battered by the pandemic-led market meltdown and can be considered for long-term gains.

Other stocks mentioned: AMN, DVA, NXGN
10 months ago - Zacks Investment Research

Let's grab these three stocks that have shown tremendous promise amid the coronavirus pandemic.

Other stocks mentioned: OMI, TMO
10 months ago - Zacks Investment Research

FMS vs. SMLR: Which Stock Is the Better Value Option?

Other stocks mentioned: SMLR
10 months ago - Zacks Investment Research

Here are some MedTech growth stocks which might be solid investment options for profit-maximization amid the coronavirus-led market mayhem.

Other stocks mentioned: ELMD, NXGN, TVTY
10 months ago - Zacks Investment Research

There are some drawbacks to using the PEG ratio though. It does not consider the very common situation of changing growth rates.

Other stocks mentioned: ALL, PHM, RBC, URI
10 months ago - Zacks Investment Research

Fresenius Medical (FMS) continues to gain traction from its broad range of dialysis products and services.

10 months ago - Zacks Investment Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest v...

10 months ago - Zacks Investment Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest v...

10 months ago - Zacks Investment Research

Fresenius Medical Care is the largest dialysis provider in the world.

11 months ago - Seeking Alpha

Fresenius (FMS) could produce exceptional returns because of its solid growth attributes.

11 months ago - Zacks Investment Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest v...

11 months ago - Zacks Investment Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest v...

11 months ago - Zacks Investment Research

FMS vs. SMLR: Which Stock Is the Better Value Option?

Other stocks mentioned: SMLR
11 months ago - Zacks Investment Research

Even though profit is a company's goal, cash is its lifeblood for existence and a measure of resiliency.

Other stocks mentioned: GFF, SMFKY, TPB
11 months ago - Zacks Investment Research

Fresenius Medical's (FMS) second-quarter earnings benefit from strong segmental performance.

11 months ago - Zacks Investment Research

Fresenius (FMS) could produce exceptional returns because of its solid growth attributes.

11 months ago - Zacks Investment Research

Fresenius SE & Co. KGaA (FSNUF) Management on Q2 2020 Results - Earnings Call Transcript

11 months ago - Seeking Alpha

Fresenius Medical Care AG & Co. KGaA (FMS) CEO Robert Powell on Q2 2020 Results - Earnings Call Transcript

11 months ago - Seeking Alpha

Fresenius CFO: Business model strong despite pandemic's challenges

YouTube video

Fresenius CFO Rachel Empey discusses the impact of the coronavirus pandemic on the health-care company's second-quarter earnings.

11 months ago - CNBC International TV

About FMS

Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage rena... [Read more...]

Industry
Medical Care Facilities
IPO Date
Sep 19, 1996
CEO
Rice Powell
Employees
124,995
Stock Exchange
NYSE
Ticker Symbol
FMS
Full Company Profile

Financial Performance

In 2020, FMS's revenue was $17.86 billion, an increase of 2.19% compared to the previous year's $17.48 billion. Earnings were $1.16 billion, a decrease of -2.94%.

Financial Statements

Analyst Forecasts

According to 6 analysts, the average rating for FMS stock is "Buy." The 12-month stock price forecast is 39.24, which is a decrease of -3.75% from the latest price.

Price Target
$39.24
(-3.75% downside)
Analyst Consensus: Buy